$18.67
0.70% yesterday
Nasdaq, Dec 24, 07:00 pm CET
ISIN
US78573L1061
Symbol
SBRA

Sabra Health Care REIT, Inc. Target price 2025 - Analyst rating & recommendation

Sabra Health Care REIT, Inc. Classifications & Recommendation:

Buy
55%
Hold
45%

Sabra Health Care REIT, Inc. Price Target

Target Price $21.42
Price $18.67
Potential
Number of Estimates 14
14 Analysts have issued a price target Sabra Health Care REIT, Inc. 2026 . The average Sabra Health Care REIT, Inc. target price is $21.42. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 20 analysts: 11 Analysts recommend Sabra Health Care REIT, Inc. to buy, 9 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Sabra Health Care REIT, Inc. stock has an average upside potential 2026 of . Most analysts recommend the Sabra Health Care REIT, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 703.24 756.74
8.61% 7.61%
EBITDA Margin 60.67% 62.26%
2.91% 2.62%
Net Margin 18.02% 25.12%
747.88% 39.42%

15 Analysts have issued a sales forecast Sabra Health Care REIT, Inc. 2025 . The average Sabra Health Care REIT, Inc. sales estimate is

$757m
Unlock
. This is
1.56% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$821m 10.19%
Unlock
, the lowest is
$693m 7.03%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $703m 8.61%
2025
$757m 7.61%
Unlock
2026
$810m 7.07%
Unlock
2027
$869m 7.19%
Unlock
2028
$923m 6.26%
Unlock
2029
$1.1b 20.38%
Unlock
2030
$1.2b 7.92%
Unlock

13 Analysts have issued an Sabra Health Care REIT, Inc. EBITDA forecast 2025. The average Sabra Health Care REIT, Inc. EBITDA estimate is

$471m
Unlock
. This is
5.99% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$494m 11.25%
Unlock
, the lowest is
$445m 0.05%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $427m 5.45%
2025
$471m 10.42%
Unlock
2026
$515m 9.26%
Unlock
2027
$539m 4.72%
Unlock
2028
$516m 4.23%
Unlock

EBITDA Margin

2024 60.67% 2.91%
2025
62.26% 2.62%
Unlock
2026
63.53% 2.04%
Unlock
2027
62.06% 2.31%
Unlock
2028
55.93% 9.88%
Unlock

10 Sabra Health Care REIT, Inc. Analysts have issued a net profit forecast 2025. The average Sabra Health Care REIT, Inc. net profit estimate is

$190m
Unlock
. This is
8.59% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$212m 21.13%
Unlock
, the lowest is
$171m 2.30%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $127m 820.86%
2025
$190m 50.04%
Unlock
2026
$196m 3.35%
Unlock
2027
$206m 4.85%
Unlock

Net Margin

2024 18.02% 747.88%
2025
25.12% 39.42%
Unlock
2026
24.25% 3.46%
Unlock
2027
23.72% 2.19%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.54 0.76
800.00% 40.74%
P/E 24.49
EV/Sales 9.27

10 Analysts have issued a Sabra Health Care REIT, Inc. forecast for earnings per share. The average Sabra Health Care REIT, Inc. EPS is

$0.76
Unlock
. This is
4.11% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.85 16.44%
Unlock
, the lowest is
$0.69 5.48%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.54 800.00%
2025
$0.76 40.74%
Unlock
2026
$0.79 3.95%
Unlock
2027
$0.83 5.06%
Unlock

P/E ratio

Current 25.58 38.17%
2025
24.49 4.24%
Unlock
2026
23.69 3.27%
Unlock
2027
22.60 4.60%
Unlock

Based on analysts' sales estimates for 2025, the Sabra Health Care REIT, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 9.41 0.32%
2025
9.27 1.51%
Unlock
2026
8.66 6.60%
Unlock
2027
8.08 6.71%
Unlock
2028
7.60 5.89%
Unlock
2029
6.31 16.93%
Unlock
2030
5.85 7.34%
Unlock

P/S ratio

Current 6.20 5.81%
2025
6.11 1.54%
Unlock
2026
5.71 6.60%
Unlock
2027
5.32 6.71%
Unlock
2028
5.01 5.90%
Unlock
2029
4.16 16.93%
Unlock
2030
3.86 7.34%
Unlock

Current Sabra Health Care REIT, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
Locked
Locked Nov 25 2025
UBS
Locked
Locked
Locked Nov 18 2025
Wells Fargo
Locked
Locked
Locked Oct 21 2025
Cantor Fitzgerald
Locked
Locked
Locked Oct 01 2025
Truist Securities
Locked
Locked
Locked Sep 03 2025
Wells Fargo
Locked
Locked
Locked Aug 27 2025
BMO Capital
Locked
Locked
Locked Aug 25 2025
Analyst Rating Date
Locked
Wells Fargo:
Locked
Locked
Nov 25 2025
Locked
UBS:
Locked
Locked
Nov 18 2025
Locked
Wells Fargo:
Locked
Locked
Oct 21 2025
Locked
Cantor Fitzgerald:
Locked
Locked
Oct 01 2025
Locked
Truist Securities:
Locked
Locked
Sep 03 2025
Locked
Wells Fargo:
Locked
Locked
Aug 27 2025
Locked
BMO Capital:
Locked
Locked
Aug 25 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today